Effectiveness of Transitional Care in Inflammatory Bowel Disease; Development, Validation, and Initial Outcomes of a Transition Success Score
- PMID: 39487645
- PMCID: PMC12041418
- DOI: 10.1093/ecco-jcc/jjae166
Effectiveness of Transitional Care in Inflammatory Bowel Disease; Development, Validation, and Initial Outcomes of a Transition Success Score
Abstract
Background and aims: The effectiveness of transition programs from pediatric to adult healthcare in adolescents with inflammatory bowel disease (IBD) is not clear, as prospective studies using validated outcome measures for transition are lacking. This study aimed to develop and validate a quantitative Transition Success Score (TSS), and to apply it in a multicenter setting to assess the effectiveness of transitional care.
Methods: The Top 10 outcome items related to a successful transition, identified through an international Delphi study with IBD stakeholders, were integrated into a generic questionnaire, the TSS. In a prospective, multicenter study, the TSS was scored by adult healthcare providers, young adult patients, and caregivers, 9-15 months after transfer of care.
Results: In 7 Dutch hospitals, 160 patients completed the TSS. The mean score was 25 (range 17-27), 25.6% of patients achieving maximum score. Hypothesis testing for construct validity revealed significant associations with characteristics related to transitional care, such as knowledge, independence, and quality of life (p < 0.005). Structural validation indicated the score was most effective at discerning lower levels of transition success. Internal consistency was acceptable (0.64). High disease burden, exacerbation during or after transfer, and certain personality profiles were associated with lower scores.
Conclusions: The TSS serves as a quantitative tool to evaluate the effectiveness of transitional care interventions and to identify IBD patients at risk of encountering challenges during the transition to adult healthcare.
Keywords: IBD; inflammatory bowel disease; transition; young adults.
© The Author(s) 2024. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation.
Conflict of interest statement
MvG received grant support for this study from ECCO, ErasmusMC, and Dr. Falk Pharma. PW has served on an organization board of a congress for Janssen. VW received a speakers fee from Mirum. HvW received lectures fee from the University of Tilburg and Health Investment. LdR collaboration (such as involved in industry-sponsored studies, investigator-initiated study, consultancy) with Abbvie, Eli Lilly, Takeda, Janssen, Medtronic, and Pfizer. LD has served on advisory boards or as speakers for Abbvie, Janssen, Sandoz, and Galapagos and has received independent research funding from Pfizer. JCE received grant support (not related to this study) from MSD and Abbvie, and a consulting fee from Janssen and Abbvie (Scientific Advisory Committee). MvP, AK, AD, MW, and DR have no conflict of interest. For more information see the ICMJE forms enclosed.
Figures




Similar articles
-
Health Care Transition Outcomes in Inflammatory Bowel Disease: A Multinational Delphi Study.J Crohns Colitis. 2019 Sep 19;13(9):1163-1172. doi: 10.1093/ecco-jcc/jjz044. J Crohns Colitis. 2019. PMID: 30766997 Free PMC article.
-
Transitional Care for Patients with Inflammatory Bowel Disease: Japanese Experience.Digestion. 2021;102(1):18-24. doi: 10.1159/000510652. Epub 2020 Oct 8. Digestion. 2021. PMID: 33032280 Review.
-
Validation and Reference Scores of the Transition Readiness Assessment Questionnaire in Adolescent and Young Adult IBD Patients.J Pediatr Gastroenterol Nutr. 2023 Sep 1;77(3):381-388. doi: 10.1097/MPG.0000000000003868. Epub 2023 Jun 22. J Pediatr Gastroenterol Nutr. 2023. PMID: 37347146
-
Value of an outpatient transition clinic for young people with inflammatory bowel disease: a mixed-methods evaluation.BMJ Open. 2020 Jan 6;10(1):e033535. doi: 10.1136/bmjopen-2019-033535. BMJ Open. 2020. PMID: 31911522 Free PMC article. Clinical Trial.
-
Spotlight on Transition in Patients With Inflammatory Bowel Disease: A Systematic Review.Inflamm Bowel Dis. 2020 Feb 11;26(3):331-346. doi: 10.1093/ibd/izz173. Inflamm Bowel Dis. 2020. PMID: 31504524
Cited by
-
Clinical and Genetic Characteristics of Pediatric Patients with Inflammatory Bowel Disease Transitioning to Adult Medicine: A Single-Center Ten-Year Experience.J Clin Med. 2025 May 27;14(11):3741. doi: 10.3390/jcm14113741. J Clin Med. 2025. PMID: 40507500 Free PMC article.
References
-
- van Rheenen PF, Aloi M, Biron IA, et al.European Crohn’s and Colitis Organisation topical review on transitional care in inflammatory bowel disease. J Crohns Colitis 2017;11:1032–8. - PubMed
-
- Philpott JR, Kurowski JA.. Challenges in transitional care in inflammatory bowel disease: a review of the current literature in transition readiness and outcomes. Inflamm Bowel Dis 2019;25:45–55. - PubMed
-
- Hait EJ, Barendse RM, Arnold JH, et al.Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists. J Pediatr Gastroenterol Nutr 2009;48:61–5. - PubMed
-
- van Gaalen MAC, van Gijn E, van Pieterson M, de Ridder L, Rizopoulos D, Escher JC.. Validation and reference scores of the transition readiness assessment questionnaire in adolescent and young adult IBD patients. J Pediatr Gastroenterol Nutr 2023;77:381–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources